Restoring Immune Defense When It Matters Most.
Advancing autologous NK cell therapies to fill critical gaps left by current cancer therapy.
Restoring Immune Defense.
When It Matters Most.
NOK Therapeutics is pioneering natural killer cell therapies that restore immune defense without lymphodepletion, delivering powerful anti-cancer effects where other therapies cannot.
Barriers in Today's
Advanced Cancer Therapy
Common modern cancer therapeutics – cell therapies, bispecific antibodies, checkpoint inhibitors, etc. – leave gaps due to:
- Severe toxicity profiles
- Requirement for lymphodepletion (for cell therapies)
- Unreliable patient responses
- Narrow mechanisms of action
The Result: A large population of elderly, frail, and heavily pre-treated patients are ineligible to receive these powerful, potentially curative therapies.
NOK's Solution:
Genetically-Unmodified, Autologous NK Cell Therapy
Autologous, Non-Engineered
NK cells harvested from and returned to the same patient without genetic modification
Lymphodepletion-Free
Administered without the harsh pre-conditioning required for CAR-T, enabling a safer profile and outpatient feasibility
Seamless Administration
Built for repeat dosing and outpatient infusions.
The Right Therapy.
At The Right Time.
Our NK cell therapy is the first explicitly designed as consolidation—safely restoring immune defense after initial treatment to extend remissions when patients need it most.